Health & Pharmaceut…

The latest health and pharmaceuticals industry and company news and analysis from FriedlNews
Page 1/9

Online Pharmacies: Dispatch of OTC Medication in Austria Allowed

As of 25 June 2015 Austrian pharmacies are allowed to sell over-the-counter pharmaceuticals online. The basis for Austrian regulations is the Falsified Medicines Directive, already transposed into Austrian law. In a regulation yet to get an opinion, duties of pharmacies will be determined.

March 3, 2015

Valneva Biotech Reduces 2014 EBITDA Loss to EUR 7.4 Mln

Listed vaccine produce Valneva, formerly Intercell, posted a preliminary EUR 7.4 million (USD 8.4 million) EBITDA loss in 2014, better than EUR 11.7 million loss a year earlier, the company said Thursday.

February 26, 2015

Health Insurance Industry Expects EUR 129 Million Deficit

Austria’s health insurance fund managers expect after several years of surplus to generate a deficit again this year. According to the latest estimates of the Chief Association of Social Insurance Agencies (Hauptverband der Sozialversicherungsträger) the deficit might reach EUR 128.9 million (USD 147 million) in 2015, which marks a hefty drop from last year’s surplus of EUR 83 million (USD 94.9 million).

February 16, 2015

Valneva Completes EUR 45 Million Capital Increase

The listed biotechnology company Valneva SE announces the completion of its capital increase with shareholders preferential subscription rights launched on January 12th, 2015. Valneva estimates net proceeds of EUR 42 millions from 18.2 million offered new shares. The new ordinary shares will be traded on Euronext and on the Prime Market segment of the Vienna Stock Exchange. The financing will mainly be used for the acquisition of Crucell Sweden AB and all assets, licenses and privileges related to Dukoral.

February 4, 2015

Space One: Former Roche Facility to Become New Technology Centre

After the shutdown of the facility of Swiss pharmaceutical group Roche in Graz, the real estate will be turned into a technology centre called "Space One” focused on medical technology, sensor technology and electronics.

January 21, 2015

Valneva and British Blink Form Joint Company

Biotechnology company Valneva formed as a result of the merger of Intercell and Vivalis, has established a joint company with the British Blink Therapeutics.

January 20, 2015

Valneva Buys Vaccine Division in Sweden, Raises Capital

Listed biotechnology firm Valneva, established by way of a merger of French Vivalis and Viennese firm Intercell, is buying Crucell Sweden for EUR 45 million (USD 54.3 million), from Dutch firm Crucell holland B.V.

January 7, 2015

Roche Pharma Buys Viennese Dutalys Biotech for up to USD 490 Mln

Swiss pharmaceutical giant Roche is taking over Vienna-based biotech firm Dutalys for up to USD 490 million (EUR 398.2 million), Roche said.

December 19, 2014

Pfizer's Agreement To Acquire Baxter’s Portfolio Of Marketed Vaccines Includes Facility in Austria

Pfizer Inc. announced that it has entered into a definitive agreement to acquire Baxter International Inc.’s portfolio of marketed vaccines for $635 million. As part of the transaction, Pfizer will also acquire a portion of Baxter’s facility in Orth, Austria, where these vaccines are manufactured.

August 1, 2014

Semperit to Realign Rubber Glove Production in Thailand

Listed chemicals group Semperit is realigning its rubber glove production activities in Thailand, i.e. the 50:50 joint venture with the Thai partner Sri Trang which runs a glove plant, Semperit said. The distribution will be realigned as of the turn of 2014 and 2015, while Semperit is also attempting to push through its rights in the JV at court, the company added.

July 18, 2014